Literature DB >> 15621265

Nanoscale anionic macromolecules for selective retention of low-density lipoproteins.

Evangelia Chnari1, Hamed B Lari, Lu Tian, Kathryn E Uhrich, Prabhas V Moghe.   

Abstract

Synthetically designed anionic nanocarriers that mimic the charge properties of glycosaminoglycans can potentially sequester low-density lipoproteins (LDL) during the treatment of atherosclerosis. In this study, we explore the LDL retentivity of 15-20 nm anionic micelles formed from amphiphilic scorpion-like macromolecules (AScMs) as building blocks. The macromolecules comprise four aliphatic chains attached to mucic acid and a linear polyethylene glycol (PEG) segment to form micellar nanocarriers with a hydrophobic core and hydrophilic corona. Dynamic light scattering and transmission electron microscopy studies indicate that the carboxylate-terminated nanocarriers (20 nm) sequester LDL (22 nm), resulting in complexes with a diameter of 60-90 nm, but neutral ethoxy-terminated nanocarriers do not retain LDL. Further, carboxylate-terminated nanocarriers consistently bound to unoxidized LDL (Relative Electrophoretic Mobility, REM=1.0) and mildly oxidized LDL (REM=1.5), but not highly oxidized LDL (REM=3.6), whereas the neutral nanocarriers displayed no preference/affinity at all, indicating that the nanocarrier-LDL binding is charge-dependent. The binding affinity of unoxidized LDL for differentially charged nanocarriers, formed from varying ratios of carboxylate- and ethoxy-terminated macromolecules, was quantified. The 100% carboxylated nanocarriers elicited the highest binding affinity (K(d)=567 nm), whereas mixed micelles elicited significantly lower levels of binding affinity. Our results highlight the promise of synthetically designed nanomaterials in lipoprotein retention, a key step in managing the escalation of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15621265     DOI: 10.1016/j.biomaterials.2004.09.038

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  16 in total

1.  Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

Authors:  Nicole M Iverson; Sarah M Sparks; Bahar Demirdirek; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Acta Biomater       Date:  2010-02-17       Impact factor: 8.947

2.  Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.

Authors:  Nicole M Iverson; Nicole M Plourde; Sarah M Sparks; Jinzhong Wang; Ekta N Patel; Pratik S Shah; Daniel R Lewis; Kyle R Zablocki; Gary B Nackman; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2011-08-03       Impact factor: 12.479

3.  Impact of ionizing radiation on physicochemical and biological properties of an amphiphilic macromolecule.

Authors:  Li Gu; Kyle Zablocki; Linda Lavelle; Stanko Bodnar; Frederick Halperin; Ike Harper; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Polym Degrad Stab       Date:  2012-06-27       Impact factor: 5.030

4.  Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: an approach for atherosclerosis imaging.

Authors:  Andrei Maiseyeu; Georgeta Mihai; Sashwati Roy; Nisharahmed Kherada; Orlando P Simonetti; Chandan K Sen; Qinghua Sun; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

5.  Tartaric acid-based amphiphilic macromolecules with ether linkages exhibit enhanced repression of oxidized low density lipoprotein uptake.

Authors:  Dalia S Abdelhamid; Yingyue Zhang; Daniel R Lewis; Prabhas V Moghe; William J Welsh; Kathryn E Uhrich
Journal:  Biomaterials       Date:  2015-03-07       Impact factor: 12.479

6.  Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.

Authors:  Rebecca A Chmielowski; Dalia S Abdelhamid; Jonathan J Faig; Latrisha K Petersen; Carol R Gardner; Kathryn E Uhrich; Laurie B Joseph; Prabhas V Moghe
Journal:  Acta Biomater       Date:  2017-05-15       Impact factor: 8.947

7.  Efficient intracellular siRNA delivery by ethyleneimine-modified amphiphilic macromolecules.

Authors:  Sarah M Sparks; Carolyn L Waite; Alexander M Harmon; Leora M Nusblat; Charles M Roth; Kathryn E Uhrich
Journal:  Macromol Biosci       Date:  2011-07-26       Impact factor: 4.979

8.  Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.

Authors:  Nicole M Plourde; Sandhya Kortagere; William Welsh; Prabhas V Moghe
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

9.  Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A.

Authors:  Sarah Hehir; Nicole M Plourde; Li Gu; Dawanne E Poree; William J Welsh; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Acta Biomater       Date:  2012-07-24       Impact factor: 8.947

10.  In silico design of anti-atherogenic biomaterials.

Authors:  Daniel R Lewis; Vladyslav Kholodovych; Michael D Tomasini; Dalia Abdelhamid; Latrisha K Petersen; William J Welsh; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2013-07-25       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.